We proposed to amend this provision for greater consistency with the proposed approach to determining participation options and new 425.600(h)(1)(iii) and (h)(2), under which for agreement periods beginning on or after January 1, 2027, an ACO determined to be inexperienced with performance-based risk Medicare ACO initiatives that is not eligible to enter the BASIC track's glide path, or an ACO that is determined to be experienced with performance-based risk Medicare ACO initiatives may enter either the BASIC track Level E for all performance years of the agreement period (among other participation options)
Delayed Gastric Emptying: GLP-1 weight loss medications slow down the digestion process, keeping you feeling fuller for longer
Kharissova OV, Rasika Dias HV, Kharisov BI, Prez BO, Jimnez-Prez VM: The greener synthesis of nanoparticles
Researchers are increasingly linking obesity risk in Mexico not only to lifestyle factors, but also to genetic and environmental predispositions, reports MBN
Rybelsus est contraindicado en pacientes con antecedentes personales o familiares de carcinoma medular de tiroides o sndrome de neoplasia endocrina mltiple tipo 2 (MEN 2)
A tripartite transcription factor network regulates primordial germ cell specification in mice
